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Abstract. The study was conducted in order to determine the antimicrobial 
susceptibility of a collection of 110 biotype I. Actinobacillus pleuropneumoniae strains to 
tiamulin using standard broth microdilution method. 
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INTRODUCTION 
 
Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine 
pleuropneumonia, a severe respiratory disease, which is a serious problem in pig production 
worldwide. The acute form of the disease is often fatal, resulting in considerable economic 
losses for pig producers (Gutiérrez-Martin et al, 2006; Zutic et al, 2008). 
Tiamulin is a pleuromutilin derivative antimicrobial used in the control and treatment 
of veterinary Gram-positive and Gram-negative pathogens, with a particular emphasis on 
infections in swine (Prescott and Walker, 2000). 
Tiamulin treatment is capable of preventing mortality, reducing or eliminating clinical 
signs and reducing or eliminating lesions of experimental pleuropneumonia. It can also 
eliminate the organism completely from diseased pigs (Taylor D.J., 2008).  
 
MATERIALS AND METHODS 
 
 A total of 110 biotype I. A. pleuropneumoniae strains, isolated between 2008 and 2011 
from lungs of diseased pigs from herds located in Hungary and Romania, were included in 
this study. The study was performed at the Diagnostic Laboratory of the Large Animal Clinic, 
Faculty of Veterinary Science, Szent István University, Üllı, Hungary.  
The strains were isolated on blood agar plates, using V factor discs (Difco). 
Identification of the strains as was based on Gram-stain, hemolysis on 5% sheep blood agar, 
positive Christie-Atkins-Munch-Petersen (CAMP) reaction, requirement of NAD and urease 
production. Strains wore stored at -80ºC and were thawn and striked on blood agar plates 
prior to use. 
All A. pleuropneumoniae isolates were tested for their in vitro susceptibility by broth 
microdilution method using veterinary fastidious medium (VFM) according to CLSI 
guidelines M07-A8 (2009) and M31-A3 (2008). VFM is cation-adjusted Mueller-Hinton 
broth supplemented with lysed horse blood, yeast extract and yeast concentrate supplement C. 
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MIC determinations were performed using 96 well microtiter plates (Greiner). Fresh, 16-20 
hours cultures were used to prepare bacterial suspensions for the MIC study. Concentration of 
bacterial suspension was adjusted to approximately 0.08-0.13 optical density (OD) at 650 nm, 
corresponding to 0.5 McFarland standard. Final dilution range of tiamulin (Sigma) was 
0.0625-32 µg/ml. After 20 hours of incubation on a microplate shaker at 37°C, optical 
densities (OD) of wells were determined with an ELISA plate reader (BioTek) at 650 nm 
wavelength. The percentage reduction was calculated by comparing the OD values of the 
control wells (C) containing no drug, with the OD of drug containing wells (D) after the OD 
values from wells containing media but no organisms (B) has been removed: 100-(D-B) x 
100/(C-B).  
Minimal inhibitory concentration was defined as the first drug concentration where 
bacterial growth was decreased by at least 85% compared to the growth control well. The 
interpretive criteria were taken from CLSI standard M31-A3 (CLSI, 2008). The following 
clinical breakpoints for tiamulin were used for the classification of A. pleuropneumoniae 
strains: ≤16 µg/ml for “susceptible” and ≥ 32 µg/ml for “resistant”.  
 
RESULTS AND DISCUSSION 
 
Distribution of MIC values is shown on Fig. 1. MICs ranged from 1 to 8 µg/ml (MIC50 
2 µg/ml, MIC90 4 µg/ml). All isolates were inhibited by 8 µg/ml and as the susceptibility 
breakpoint was established at ≤16 µg/ml, these 110 A. pleuropneumoniae isolates were all 
considered susceptible to tiamulin. 
 
 
 
Fig. 1. Tiamulin MIC distribution of 110 A. pleuropenumoniae strains 
 
Similar in vitro MIC studies have been reported by a number of authors. Early 
publications did not always use the current CLSI guidelines, and therefore may not be directly 
comparable with those of today. Aarestrup and Jensen (1999) classified 40 A. 
pleuropneumoniae isolates from Denmark as susceptible to tiamulin using the agar 
microdilution method. The breakpoint used for resistance was ≥16 mg/ml. Jones et al. (2002) 
used the current CLSI guidelines and found that the MIC50 for 170 isolates of A. 
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pleuropneumoniae was 8 µg/ml, and the MIC90 was 16 µg/ml. Matter et al. (2007), describing 
in vitro susceptibility of 83 A. pleuropneumoniae isolates collected in Switzerland between 
2002 and 2004 to 20 antimicrobial agents, showed that only nine (11%) of their isolates were 
resistant to tiamulin. They used the same accepted breakpoints. The study reported by 
Kucerova et al. (2011) on the antimicrobial susceptibility of 242 A. pleuropneumoniae 
isolates collected from diseased pigs in the Czech Republic between 2007 and 2009 to 16 
antimicrobial agents also showed low resistance (1.7%) to tiamulin. 
 
CONCLUSIONS 
 
Hungarian and Romanian isolates of biotype I. A. pleuropneumoniae were highly 
susceptible to tiamulin. Due to this lack of resistance, tiamulin is a superior choice than many 
other antimicrobial agents for the prevention and treatment of A. pleuropneumoniae. 
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